Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-08-25
1998-06-16
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
A61K 3170
Patent
active
057671060
ABSTRACT:
A method of treating a human having a disease or condition characterized by macrophage, neutrophile or other white blood cell infiltration into the area damaged by the disease or condition, the method comprising administering to the human an effective amount of hyaluronic acid and/or salts thereof for a period of time until the administration is no longer required.
REFERENCES:
patent: 2583096 (1952-01-01), Hadidian et al.
patent: 3042667 (1962-07-01), Flodin et al.
patent: 3357784 (1967-12-01), Kasper et al.
patent: 3396081 (1968-08-01), Billek et al.
patent: 3436454 (1969-04-01), Nouvel
patent: 3792164 (1974-02-01), Bechtold et al.
patent: 3845201 (1974-10-01), Haddad et al.
patent: 3870791 (1975-03-01), Haddad et al.
patent: 3887703 (1975-06-01), Manoussos et al.
patent: 4003991 (1977-01-01), Krohn et al.
patent: 4045558 (1977-08-01), Smith et al.
patent: 4061722 (1977-12-01), Bodor et al.
patent: 4141973 (1979-02-01), Balazs
patent: 4240163 (1980-12-01), Galin
patent: 4255415 (1981-03-01), Chrai et al.
patent: 4271143 (1981-06-01), Schoenwald et al.
patent: 4272522 (1981-06-01), Balazs
patent: 4280954 (1981-07-01), Yannas et al.
patent: 4303676 (1981-12-01), Balazs
patent: 4328803 (1982-05-01), Pape
patent: 4470975 (1984-09-01), Berger et al.
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4487865 (1984-12-01), Balazs et al.
patent: 4500676 (1985-02-01), Balazs
patent: 4517295 (1985-05-01), Bracke
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4629623 (1986-12-01), Balazs et al.
patent: 4636524 (1987-01-01), Balazs et al.
patent: 4684627 (1987-08-01), LeVeen et al.
patent: 4686288 (1987-08-01), Lormeau et al.
patent: 4711780 (1987-12-01), Fahim
patent: 4713448 (1987-12-01), Balazs et al.
patent: 4716224 (1987-12-01), Sakurai et al.
patent: 4725585 (1988-02-01), Wenge et al.
patent: 4736024 (1988-04-01), Della Valle et al.
patent: 4746504 (1988-05-01), Nimrod et al.
patent: 4755544 (1988-07-01), Makino et al.
patent: 4782046 (1988-11-01), Brown et al.
patent: 4784990 (1988-11-01), Nimrod et al.
patent: 4784991 (1988-11-01), Nimrod et al.
patent: 4795741 (1989-01-01), Leshchiner et al.
patent: 4801619 (1989-01-01), Lindblad
patent: 4804537 (1989-02-01), Bergman et al.
patent: 4808576 (1989-02-01), Schultz et al.
patent: 4814175 (1989-03-01), Tack et al.
patent: 4820732 (1989-04-01), Shell et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 4853224 (1989-08-01), Wong
patent: 4853226 (1989-08-01), Machida et al.
patent: 4855134 (1989-08-01), Yamahira et al.
patent: 4863907 (1989-09-01), Sakurai et al.
patent: 4877619 (1989-10-01), Richer
patent: 4879282 (1989-11-01), Saliba, Jr.
patent: 4912093 (1990-03-01), Michaeli
patent: 4913898 (1990-04-01), Altobelli et al.
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 4937270 (1990-06-01), Hamilton et al.
patent: 4944941 (1990-07-01), Ammann
patent: 4957744 (1990-09-01), della Valle
patent: 4963666 (1990-10-01), Malson
patent: 4965353 (1990-10-01), della Valle
patent: 5092841 (1992-03-01), Spears
patent: 5095037 (1992-03-01), Iwamitsu
patent: 5116331 (1992-05-01), della Valle
patent: 5116864 (1992-05-01), March et al.
patent: 5202431 (1993-04-01), della Valle et al.
Abatangelo G, Martelli M, Vecchia P. Healing of hyaluronic acid-enriched wounds: Histological observations. J. Surgical Research 1983; 35: 410-416.
Abatangelo G, Corvito R, et al. Cell detachment mediated by hyaluronic acid. Exp. Cell Res. 1982; 137: 73-78.
Adams JB Steroid hormones and breast cancer. Dissertation Abstracts International 1981; 42(4): 1425B.
Ahlgren T, Jarstrand C. Hyaluronic acid enhances phagocytosis of human monocytes in vitro. J Clinical Immunology 1984; 4(3): 246-249.
Alaverdyan MI, Ter-Avetisyan AT. Effect of hyaluronidase, hyaluronic acid, and some other substances on postradiational experimental bacteriemai. Bulletin of Experimental Biology and Medicine 1967; 64(9): 967-969.
Alexander P. Ageing skin: Remedial measures. Manuf. Chemist 1985; Oct.: 35, 37, 39.
Altman RD, Kapila P, Dean DD, Howell DS. Future therapeutic trends in osteoarthritis. Scand. J. Rheumatology 1989; Suppl. 77: 37-42.
Ambroggio G, Barberis ML Trattamento di lesioni cutanee ad andamento cronico con acido ialuronico. Minerva Chirurgica 1969; 23(15): 815-818.
Anastassiades T, Robertson W Modulation of mitogen-dependent lymphocyte stimulation by hyaluroniccid. J Rheum. 1984; 11(6): 729-734.
Appel A, Horwitz AL, Dorfman A. Cell-free synthesis of hyaluronic acid in marfan syndrome. J Biological Chemistry 1979; 254(23): 12199-12203.
Arzeno G. Miller D. Effect of sodium hyaluronate on corneal wound healing. Arch Ophthalmol 1982; 100: 152.
Aste L, Burattoni G. Osservazioni sull'impiego dell'acido jaluronico nel trattamento delle ulcere da decubito nelle sindromi midollari. Ospedali D'Italia Chirurgia 1967: 17(3): 315-322.
Balazs EA, Band P. Hyaluronic acid: Its structure and use. Cosmetics & Toiletries. Polymers in Cosmetics 1984; 99: 65-72.
Balazs EA, Freeman MI, et al. Hyaluronic acid and replacement of vitreous and aqueous humor. Modern Problems in Ophthalmology: Secondary Detachment of the Retina 1971; 10: 3-21.
Balazs EA, Gibbs DA. The rheological properties and biological function of hyaluronic acid. In: Chemistry and Molecular Biology of the Intercellullar Matrix. Vols. III. New York: Academic Press, 1970. pp. 1241-1253.
Barondes SH. Bifunctional properties of lectins: Lectins redefined. TIBS 1988; 13 (Dec.): 480-482.
Barron BA, et al. Comparison of the effects of viscoat and healon on postoperative intraocular pressure. Am. J. Ophthallmology 1985; 100: 377-384.
Bayer EA, Wilcher M. The use of the avidin-biotin complex as a tool in molecular biology. Methods of Biochemical Analysis. Vol. 26: 1-45.
Ber A, Mikolajczyk H. Badania nad ukladem hialuronidaza--kwas hialuronowy. Wplyw kwasu hialuronowego na gojenie sie doswiad-czalnych wrzodow zoladka u szczurow. Patologia Polska 1957; 8: 31-36.
Biggar WD, Sturgess JM. Role of lysozyme in the microbicidal activity of rat alveolar macrophages. Infection and Immunity 1977; 16(3): 974-982.
Billek G, Billek D. Hyaluronsaure -Die Gesch . . . eines kosmetischen 768-790 & 792-795.
Binkhorst CD. Advantages and disadvantages of intracamerular Na-Hyaluronate (Healon) in intraocular lens surgery. Documenta Ophthalmologica 1981; 50: 233-235.
Blumenkrantz N, Asboe-Hansen G. Reaction of cationic groups of chlorpromazine with anionic macromolecules: Complexes with DNA, RNA, hyaluronic acid and heparin. Acta Pharmacol. et Toxiicol. 1974; 34: 27-32.
Boutet D, Voskamp K. L'acide hyaluronique: Proprietes et applications. Parfums, Cosmetiques, Aromes 1986; 68: 53-56.
Bowen BR, Nguyen T, Lasky LA. Characterization of a human homologue of the murine peripheral lymph node homing receptor. J Cell Biology 1989; 109(Jul.): 421-427.
Boyce ST, Christianson DJ, Hansbrough JF. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J. Biomedical Material Research 1988; 22: 939-957.
Brandstetter W, Kiesewetter E, Wohlzogen FX. Influencing experimental Beeinflussung experimentell-pathologischer veranderungen bei nagern durch hyaluronsaure.! Archive for Experimental Pathology and Pharmacology/Archiv Fur Experimentelle Pathologie 1957; 231(2): 186-198.
Brandt K. Modification of chemotaxis by synovial fluid hyaluronate. Arthritis and Rheumatism 1970; 13(3): 308-309.
Brown TA, Bouchard T, St. John T, Wayner E, Carter WG. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membane proteoglycan with additional exons. J Cell Biology 1991; 113(1): 207-221.
Bruno RN. Osservazioni sull'impiego comparativo di sale sodico dell'acido ialuronico e dell'estratto di Triticum vulgaris in 20 casi di soggetti Policlinico. Sezione Medica: 1983; 90(4): 340-344.
Burk DT. Morphological effects of streptomyces hyaluronidase treatment on the ouitgrowth of the nasal processes in mouse embryos. J Craniofacial Genetics 1985; 5: 385-398.
Buu-Hoi NG, PH. La B-hydroxypropiophenone, ses analogues et leurs derives. Recueil Trav. Chim. Pays-Bas 1949
Asculai Samuel Simon
Turley Eva Anne
Hughes Ivor M.
Hughes Neil H.
Hyal Pharmaceutical Corporation
Peselev Elli
Sarkis Marcelo K.
LandOfFree
Treatment of disease and conditions associated with macrophage i does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of disease and conditions associated with macrophage i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of disease and conditions associated with macrophage i will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726197